Your browser doesn't support javascript.
loading
High Expression of Urokinase-Type Plasminogen Activator Is Associated with Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast / 한국유방암학회지
Journal of Breast Cancer ; : 156-162, 2016.
Article in English | WPRIM | ID: wpr-166638
ABSTRACT

PURPOSE:

In the present study, we evaluated the levels of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1) by performing immunohistochemical staining to determine whether they were reliable prognostic markers in patients with breast cancer.

METHODS:

Demographic and clinicopathological parameters of 214 patients with invasive ductal carcinoma (IDC) and 80 patients with ductal carcinoma in situ (DCIS) who were diagnosed and treated from 2006 to 2010 were analyzed. Tissue microarray was constructed and immunohistochemical staining was performed for each specimen.

RESULTS:

Univariate analyses showed that age at diagnosis, history of hormone replacement therapy, radiation therapy, skin and chest wall invasion, Paget disease, lymphovascular invasion, estrogen receptor positivity, and triple-negative subtype were significantly associated with patient prognosis (p<0.005). Patients with DCIS showed higher PAI-1 expression than patients with IDC (82.5% and 36.2%, respectively; p=0.012). Lymph node metastasis was more frequent in patients with high uPA levels than in patients with low uPA levels (p=0.001).

CONCLUSION:

Our results suggested that PAI-1 was involved in tumor progression in the early stages of breast cancer, such as DCIS. In addition, our results suggested that high uPA levels were associated with the lymph node metastasis of IDC.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Skin / Breast / Breast Neoplasms / Urokinase-Type Plasminogen Activator / Plasminogen Activator Inhibitor 1 / Carcinoma, Intraductal, Noninfiltrating / Hormone Replacement Therapy / Thoracic Wall / Carcinoma, Ductal Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Journal of Breast Cancer Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Skin / Breast / Breast Neoplasms / Urokinase-Type Plasminogen Activator / Plasminogen Activator Inhibitor 1 / Carcinoma, Intraductal, Noninfiltrating / Hormone Replacement Therapy / Thoracic Wall / Carcinoma, Ductal Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Journal of Breast Cancer Year: 2016 Type: Article